Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 6.09
+0.02 (0.33%)
Sep 30, 2026, 1:27 PM CST
Merdury Biopharmaceutical Market Cap
Merdury Biopharmaceutical has a market cap or net worth of 2.6 billion as of September 29, 2026. Its market cap has increased by 13.20% in one year.
Market Cap
2.60B
Enterprise Value
2.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.09
ChartMarket Cap Chart
Since December 23, 2022, Merdury Biopharmaceutical's market cap has decreased from 5.10B to 2.60B, a decrease of -49.14%. That is a compound annual growth rate of -16.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 2.60B | -25.26% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LIWANLI Innovation | 4.74B |
| Panion & Bf Biotech | 4.62B |
| Orient EuroPharma | 4.00B |
| Easywell Biomedicals | 3.54B |
| Maywufa Company | 2.77B |
| Allied Biotech | 2.75B |
| PhytoHealth | 2.25B |
| Tien Liang BioTech | 2.17B |